News

In This Article This article contains: The Limitations of One-Size-Fits-All Supplementation Why Personalized Formulations Drive Better Outcomes A Practical Guide to Implementing Custom Supplements Frequently Asked Questions About Custom Formulations Elevating the Standard of Integrative Cardiac Care If you work with...

The leading pharmaceutical industry conferences of 2026 fall into a few distinct categories, and the smartest commercial teams treat them as a portfolio rather than a single choice. That distinction matters more every year. Scientific progress and commercial strategy convert...

The pharmaceutical industry is continually evolving to improve patient care, treatment outcomes, and convenience. One of the most significant innovations in recent years is the development of wearable injectors, which are transforming the way large-volume medications are administered. These...

Dimethyl sulfoxide (DMSO) is one of the most widely used solvents in pharmacological research. Its ability to dissolve a broad range of organic compounds including many that are poorly soluble in aqueous media has made it a default choice...

Insilico Medicine has reached a significant clinical milestone with the completion of first-in-human dosing of ISM8969 in a Phase 1 study. Conducted in collaboration with Hygtia Therapeutics, the ISM8969 Phase 1 trial marks the transition of this oral, brain-penetrant...

Access to quality healthcare remains a challenge for many people living in rural communities. Long travel distances, limited provider availability, and healthcare workforce shortages often make it difficult to receive timely medical attention. Fortunately, telehealth care in New Hampshire...

Moderna is strengthening its commercial leadership and operational structure as it prepares for a series of anticipated vaccine launches over the next several years. The company expects potential introductions of its mRNA-based seasonal flu vaccine, combined flu/COVID-19 vaccine, and...